AstraZeneca files Form 6-K
AstraZeneca filed a Form 6-K on October 27.
Related stories
Megan Holdings Closes $7.5 Million Follow-on Public Offering
Megan Holdings Limited said it closed a $7.5 million follow-on public offering.
M impact | EQUITY | Oct 29, 2026, 03:12 PM UTC
Bausch Health Hits 52-Week High After Quarterly Earnings
Bausch Health reached $11.89, a 52-week high. Its quarterly earnings were $1.77 per share, compared with the Zacks consensus estimate of $1.08 and $1.16 a year earlier.
M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC
Jordan Decapolis Properties Reports Q3 Loss of 22,762 Dinars
M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC
Microsoft Guides for Q2 Revenue of $96 Billion to $97.1 Billion
Microsoft expects revenue and Azure growth to accelerate in the December quarter as delayed AI infrastructure spending shifts into the fiscal year's second half. Its Q2 revenue gui
M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC
PHINIA Reports Quarterly Sales of $912M, Net Earnings of $67M
PHINIA reported quarterly net sales of $912 million and net earnings of $67 million, compared with $908 million and $13 million a year earlier. Diluted EPS was $1.80, up from $0.33
M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC
Iovance shares fall more than 32% after updated lung cancer trial results
Shares fell more than 32% on Thursday, putting the stock on track for its worst session since May 2025. The sell-off followed updated lung cancer trial results.
M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC